What is menopause that occurs before 45 and before 40?
<45 = early menopause <40 = ovarian failure
What is the commonest clinical ovarian disorder?
ovarian cysts (non-neoplastic - small)
What are the types of non-neoplastic ovarian cysts (small)?
- PCOS
What are the types of ovarian neoplastic cysts (large)?
Why are ovarian cysts typically quite large?
- therefore –> lots of time for growth of tumor
What are the 2 phases of ova development?
2. luteal phase
What do the abnormal follicles in PCOS produce?
increased androgens AND estrogens –> clinical features
What % of teens/young adults get PCOS?
6-10%
What are the clinical features of PCOS?
What happens to follicle development in PCOS?
instead of graafian follicles undergoing normal ovulation, they become cysts
What is the possible outcome of increased estrogens in PCOS?
-increased risk of endometrial hyperplasia and cancer
What is the pathology of PCOS?
Irregular bleeding in a patient since menarche with hirsutism and normal 17 hydroxyprogesterone levels suggests what?
PCOS
Irregular bleeding in a patient since menarche with increased 17hydroxyprogesterone levels suggests what?
CAH (congenital adrenal hyperplasia)
What is menopause?
-physiological cessation of ovulation, menstrual cycles with associated genital atrophy
What are the characteristic hormone levels in menopause?
inhibin inhibits FSH
Why are there short anovulatory cycles in menopaue?
due to rapid follicle maturation from increased FSH (+decreased inhibin = decreased neg. feedback on FSH)
What is diagnostic of menopause with regards to hormone levels?
- FSH > LH = diagnostic
What are the clinical features of menopause?
What are the diagnostic criteria for PCOS?
*at least 2 out of the following 3:
What hormone is measured to differentiate between CAH and PCOS in a pt. with irregular bleeding since menarche?
17OHP
-17 hydroxyprogesterone
What is commonly used to treat Sx. of menopause?
HRT
What are the pros and cons of HRT?
Pros:
Cons:
What is the epidemiology of ovarian neoplasms?
80% benign, cystic, young (<50)
20% malignant, solid, older (>50)